Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 12, 2023

SELL
$8.79 - $14.58 $67,392 - $111,784
-7,667 Reduced 11.91%
56,695 $532,000
Q2 2021

Aug 10, 2021

SELL
$28.76 - $35.98 $11,504 - $14,391
-400 Reduced 0.62%
64,362 $2.23 Million
Q1 2021

May 14, 2021

SELL
$27.85 - $34.49 $801,077 - $992,070
-28,764 Reduced 30.76%
64,762 $1.91 Million
Q4 2020

Feb 12, 2021

BUY
$27.53 - $33.79 $6,689 - $8,210
243 Added 0.26%
93,526 $2.87 Million
Q2 2020

Jul 24, 2020

BUY
$18.94 - $24.93 $5,606 - $7,379
296 Added 0.32%
93,283 $2 Million
Q3 2019

Oct 08, 2019

BUY
$25.62 - $34.96 $712,876 - $972,762
27,825 Added 42.7%
92,987 $2.47 Million
Q2 2019

Jul 10, 2019

BUY
$31.11 - $34.79 $37,332 - $41,748
1,200 Added 1.88%
65,162 $2.2 Million
Q1 2019

Apr 18, 2019

BUY
$29.0 - $32.83 $1.85 Million - $2.1 Million
63,962 New
63,962 $2.05 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.73B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Gulf International Bank (Uk) LTD Portfolio

Follow Gulf International Bank (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.